Wang, S., Xu, R., Huang, J., Xia, W., Ruan, D., Xu, F., Liu, F., Sun, Y., Ma, Y., Zheng, Q., Niu, Z., Wan, L., Hong, R., Wang, X., Li, N., An, X., Chao, C., Song, S. Q., Yu, J. (2025). A phase Ib/IIa study of BAT8010+BAT1006, an anti-HER2 monoclonal antibody-exatecan conjugate combined with an ADCC-enhanced HER2 mAb in patients with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1027